−0.378 CHF
−19.39 M CHF
9.40 M CHF
8.99 M
About HEIDELBERG PHARMA AG
Sector
CEO
Andreas Pahl
Headquarters
Ladenburg
Website
Founded
1997
ISIN
DE000A11QVV0
FIGI
BBG00LVDK007
Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The firm focuses on oncology; and development Amanitin, a toxin used in cancer therapies. It also offers tumor implantation models, inflammatory and autoimmune diseases, and bioanalytics services. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange HEIDELBERG PHARMA stocks are traded under the ticker HPHA.
HPHA stock has risen by 0.95% compared to the previous week, the month change is a 0.95% rise, over the last year HEIDELBERG PHARMA has showed a 0.95% increase.
We've gathered analysts' opinions on HEIDELBERG PHARMA future price: according to them, HPHA price has a max estimate of 11.18 CHF and a min estimate of 8.27 CHF. Watch HPHA chart and read a more detailed HEIDELBERG PHARMA stock forecast: see what analysts think of HEIDELBERG PHARMA and suggest that you do with its stocks.
HPHA reached its all-time high on Jan 3, 2025 with the price of 2.343 CHF, and its all-time low was 2.321 CHF and was reached on Jan 3, 2025. View more price dynamics on HPHA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HPHA stock is 0.95% volatile and has beta coefficient of 0.32. Track HEIDELBERG PHARMA stock price on the chart and check out the list of the most volatile stocks — is HEIDELBERG PHARMA there?
Today HEIDELBERG PHARMA has the market capitalization of 109.15 M, it has increased by 8.86% over the last week.
Yes, you can track HEIDELBERG PHARMA financials in yearly and quarterly reports right on TradingView.
HPHA net income for the last quarter is −5.25 M CHF, while the quarter before that showed −4.08 M CHF of net income which accounts for −28.65% change. Track more HEIDELBERG PHARMA financial stats to get the full picture.
No, HPHA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 23, 2025, the company has 105.00 employees. See our rating of the largest employees — is HEIDELBERG PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEIDELBERG PHARMA EBITDA is −19.10 M CHF, and current EBITDA margin is −270.21%. See more stats in HEIDELBERG PHARMA financial statements.
Like other stocks, HPHA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEIDELBERG PHARMA stock right from TradingView charts — choose your broker and connect to your account.